The case for early combined hormonal and cytostatic treatment for metastatic prostatic carcinoma.
Servadio
C
C
Department of Urology, Beilinson Medical Center, Petah Tiqva, Israel.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004054:Diethylstilbestrol / Q000627:therapeutic use*; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000473:pathology / Q000628:therapy*; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000473:pathology / Q000628:therapy*; D013997:Time Factors
D004054:Diethylstilbestrol; D003520:Cyclophosphamide; D005472:Fluorouracil